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Syncope is a common medical problem, with a frequency between 15% and 39%. In
the general population, the annual number episodes are 18.1–39.7 per 1000 patients,
with similar incidence between genders. The first report of the incidence of syncope
is 6.2 per 1000 person-years. However, there is a significant increase in the incidence
of syncope after 70 years of age with rate annual 19.5 per thousand individuals after
80 years. It presents a recurrence rate of 35% and 29% of physical injury. Among the
causes of syncope, the mediated neural reflex, known as neurocardiogenic or vasovagal
syncope, is the most frequent. The others are of cardiac origin, orthostatic hypotension,
carotid sinus hypersensitivity, neurological and endocrinological causes and psychiatric
disorders. The diagnosis of syncope can be made by clinical method associated with the
electrocardiogram in up 50% of patients. Its prognosis is determined by the underlying
etiology specifically the presence and severity of cardiac disease. The annual mortality can
reach between 18 and 33% if cardiac cause, and between 0 and 12% if the non-cardiac
cause. Thus, it is imperative to identify its cause and risk stratification for positive impact
in reducing morbidity and mortality.
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DEFINITION AND EPIDEMIOLOGY
Syncope is the sudden loss of consciousness, associated with
inability to maintain postural tone, with immediate and
spontaneous recovery without requiring electrical or chemical
cardioversion. This framework is secondary to cerebral hypop-
erfusion, with short duration (average 12 seconds). It has a
prevalence of 42%, considering a life time of 70 years and an
annual incidence of 6% (Moya et al., 2009). Its frequency varies
from 15% (below 18 years of age) (Lewis and Dhala, 1999) to 39%
(among medical students) (Serletes et al., 2006), reaching 23%
among the elderly (Lipsitz et al., 1985). In the general popula-
tion, the annual number episodes are 18.1–39.7 per 1000 patients,
with similar incidence between genders, and with high preva-
lence between 10 and 30 years of age, mainly of vasovagal syncope
(Moya et al., 2009). The first report of the incidence of syn-
cope is 6.2 per 1000 person-years. However, there is a significant
increase in the incidence of syncope after 70 years of age, with
5.7 episodes/1000 individuals per year between 60 and 69 years
old and with 11.1 episodes/1000 individuals per year between 70
and 79 years age. After 80 years, the annual incidence may reach
19.5 per 1000 individuals (Soteriades et al., 2002; Colman et al.,
2004).
This framework is responsible for 3–5% of emergency depart-
ment visits, with a hospitalization rate in about 40% of cases,
with an average stay of 5.5 days. Beyond this morbidity, there
is a recurrence rate of approximately 35% and 29% of physical
injury, and major trauma in 4.7% of patients. In elderly patients
with syncope due to carotid sinus hypersensitivity, the prevalence
of trauma may reach 43% (Brignole et al., 2006; Moya et al.,
2009). Besides the social impact with worsening quality of life,
there is also the economic impact, with higher costs attributed
to hospitalization with an estimated $2.4 billion annual cost
(Sun, 2013).
ETIOLOGY
Among the causes of syncope, the mediated neural reflex, known
as neurocardiogenic or vasovagal syncope, is the most frequent,
accounting for one third of the causes and reaching 66% of cases
in emergency units (Alboni et al., 2001; Brignole et al., 2006). The
diagnosis of syncope can be made by clinical method associated
with the electrocardiogram in up 50% of patients (Moya et al.,
2009). The clinical history should be performed with proficiency,
and each episode of syncope should be well characterized about
presence of prodrome, precipitating factors, conditions in which
it occurred, position of the patient, and other associated signs
such as nausea, pallor, diaphoresis, muscle twitching, confusion,
physical injury, palpitations, dyspnea, chest pain, and cyanosis.
The personal medical history and family history are also impor-
tant to identify the cause of syncope. The Calgary Score is one
of the diagnostic tools, including seven clinical issues and allow
diagnosis vasovagal syncope with 89% sensitivity and 91% speci-
ficity (Sheldon et al., 2006). The physical examination should
be comprehensive, including measurement of blood pressure in
the supine position and within 3min in the orthostatic posi-
tion, the blood pressure measurements in both arms (to detect
subclavian steal), and the exam of the cardiovascular system,
which can identify signs of disease and/or arrhythmias, and other
systems.
The main causes of syncope are summarized in Table 1 and
will be discussed below.
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Table 1 | Common causes of syncope.
Pathophysiological Causes
origin
Reflex syncope Vasovagal, situational syncope, orthostatic
hypotension, carotid sinus hypersensitivity
Cardiac syncope Structural heart disease, bradyarrhythmias,
tachyarrhythmias
Neurological causes Cerebrovascular disease, autonomic
dysfunction, subclavian steal syndrome
Others causes Endocrinological causes, psychiatric
disorders
VASOVAGAL SYNCOPE
This term was first used byWilliam Gowers in 1907 and described
the mechanism of vasovagal syncope by Thomas Lewis in 1932
(Lewis, 1932). It shows bimodal distribution, but is most com-
mon in young people. Precipitating factors are prolonged sitting
position or standing position, emotional stress, pain, heat, venous
puncture, alcohol use, dehydration, use of diuretics and vasodila-
tors. Prodromes of nausea, vomiting, abdominal pain, diaphore-
sis, pallor, palpitations, and dizziness may occur and are more
common in young people. After loss of consciousness, tonic-
clonic contractions, if they occur, are of short duration (<15 s).
There are no aura, headache, sleep, sphincter release, mental con-
fusion, and duration of loss of consciousness greater than 5min,
such as occurs in epilepsy (Kapoor, 2002; Moya et al., 2009).
The neuromediated syncope is called situational syncope when
it occurs in conditions that trigger the Valsalva maneuver, such as
urination, defecation, coughing, visceral pain, carry weight.
The mechanism of vasovagal syncope is explained by the
Bezold–Jarisch reflex, which is triggered due to decreased venous
return resulting in inadequate ventricular filling and vigorous car-
diac contraction. It occurs by the action of mechanoreceptors
(C fibers) preferentially located in the inferolateral wall of the
left ventricle, but also in the atria and in the pulmonary artery,
and manifests with hypotension and paradoxical bradycardia
due to increased activity of inhibitory receptors and consequent
parasympathetic hyperactivity (Medow et al., 2008; Moya et al.,
2009).
Initial therapy of vasovagal syncope is non-pharmacological.
The recommendations are to identify and avoid the precipitat-
ing factors, assuming the supine position during the period of
prodromes, and nutritional guidelines. These include hydration
with fluid intake 2–2.5 liters per day and sodium supplemen-
tation. Aerobic and isometric exercises of the upper and lower
limbs reduce the recurrence of vasovagal syncope. Tilt training
compared with conventional treatment shows limited efficacy in
controlled studies. The use of compression stockings in the lower
limbs may be recommended, however it has limited efficacy and
poor adherence. If failure of initial recommendations, the next
step is pharmacological treatment with the use of fludrocorti-
sone if vasodepressor response. Beta blockers are contraindicated.
Implantation of a pacemaker is class IIa indication for patients
over 40 years of age and cardioinhibitory response with asystole
(Moya et al., 2009; Raj and Coffin, 2013).
CARDIAC CAUSES
The causes are structural heart diseases or conditions that result
in decreased cardiac output such as aortic stenosis, hypertrophic
cardiomyopathy, ischemic heart disease, heart failure, aortic dis-
section, cardiac tamponade, prosthetic valve thrombosis, cardiac
tumors, pulmonary hypertension, pulmonary embolism etc. Both
bradyarrhythmias and tachyarrhythmias are frequent causes of
cardiac syncope due to impaired cardiac output secondary to the
frequency of the arrhythmia, its origin, to systolic ventricular dys-
function. A family history of sudden cardiac death is an important
data for the hypothesis channelopathy (Moya et al., 2009; Rosanio
et al., 2013). Treatment depends on the cause cardiac syncope,
with treatment directed to the structural heart disease, pace-
maker implantation, if bradyarrhythmias, or use of antiarrhyth-
mic, catheter ablation or implantable cardioverter-defibrillator, if
tachyarrhythmias (Moya et al., 2009).
ORTHOSTATIC HYPOTENSION
Orthostatic or postural hypotension (OH) presents as falls, dizzi-
ness, or syncope, resulting in functional impairment, with head
injury, bone fractures and hospitalization. It is more common
in the elderly, with frequency rates of up to 55% in those that
residing in institutions, and with prevalence of 12%. Its clas-
sic definition is a drop of at least 20mmHg in systolic and/or
10mmHg in diastolic blood pressure within 3min to take an
orthostatic position. There are other presentations such as initial
OH, when there is a greater than 40mmHg drop in blood pres-
sure, with less than 30 s in duration, and progressive OH, when
the fall of blood pressure levels are gradual, between 3 and 30min
after taking standing position, without bradycardia (Goldstein
and Sharabi, 2009; Moya et al., 2009).
Beyond the control of the precipitating factor, hydration
and salt intake, treatment of syncope postural hypotension can
be done with fludrocortisone, midodrine. Other measures are
abdominal compression and elevation of the head of the bed
(Moya et al., 2009; Raj and Coffin, 2013).
Postprandial hypotension is a common cause of syncope in
the elderly, with a prevalence that can reach 67%, especially in
the elderly who live in institutions. It is defined as the drop of at
least 20mmHg in systolic blood pressure or absolute value of the
systolic pressure lower than 90mmHg (those with systolic blood
pressure of at least 100mmHg), within 2 h after meals. The patho-
physiology is due to sympathetic dysfunction, with inadequate
peripheral vasoconstriction and insufficient heart rate increase.
Precipitating factors are vasodilators, high temperature of food or
of environment and diets high in carbohydrates (Luciano et al.,
2010).
CAROTID SINUS HYPERSENSITIVITY
It is an extrinsic sinus node disease that is characterized by
pre-syncope or syncope exacerbated by the carotid sinus reflex
response. Its incidence is 35–40 patients/year/million individu-
als, with a predominance in males (male:female ratio of 4:1)
and more frequent in the elderly, especially diabetics with coro-
nary or carotid atherosclerosis. Precipitating factors are sudden
movements of the head and neck, cervical compressions and
use of tight neck tie (Healey et al., 2004). The approach of the
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carotid sinus syndrome includes the implantation of a pacemaker
if cardioinhibitory response, or use of volumetric expansion, if
vasodepressor response.
NEUROLOGICAL CAUSES
Neurological causes are cerebrovascular disease, autonomic dys-
function and subclavian steal syndrome. Focal neurological
deficits in stroke, vertebrobasilar transient ischemic stroke,
migraine (for vasospasm or vasovagal reflex) may be presented
as syncope.
The primary autonomic dysfunction occurs in pure primary
dysfunction syndrome (Bradbury–Eglleston), in central nervous
system diseases (Parkinson’s disease, multiple system atrophy or
Shy–Drager syndrome, Huntington’s disease and Guillain–Barré
syndrome). Secondary dysfunctions occur by changes of aging,
due to the involvement of the peripheral nervous system in dia-
betes mellitus, renal failure, alcoholism, amyloidosis; infections
of the nervous system by Chagas disease, human immunodefi-
ciency virus; metabolic diseases such as vitamin B12 deficiency,
porphyria; autoimmune diseases such as rheumatoid arthritis and
others. And as antihypertensive drugs (diuretics, vasodilators),
anti-depressants may also cause autonomic dysfunction (Azhar
and Lipsitz, 1998).
The first report of subclavian steal syndrome was described in
1960 by Contorni. It shows a prevalence of up to 6.4%. There
is malformation or obstruction by atherosclerosis of the proxi-
mal subclavian artery to the origin of vertebral artery, resulting in
retrograde flow in this artery. It occurs mainly in the left subcla-
vian artery. Neurological symptoms, such as dizziness, paresthesia
and syncope, occur during exercise performed by the arm, but
patients may present framework of transient ischemic attacks
(Osiro et al., 2012; Potter and Pinto, 2014).
OTHERS CAUSES
There are endocrinological causes that can be presented as
orthostatic hypotension to cause autonomic dysfunction or
hypovolemia. As examples, chronic adrenal insufficiency and
hypopituitarism can be cited. Diabetes insipidus and salt-
losing nephropathies since they result in volume depletion, and
pheochromocytoma and carcinoid syndrome, due to vasoactive
substances, can also be causes of syncope. Hyperventilation and
psychiatric disorders, due to cerebral hypoperfusion, are other
causes of syncope (Kapoor, 2002; Moya et al., 2009).
PROGNOSIS
The pathophysiology, approach, prognosis and treatment depend
on the cause of syncope, andmandatory their identification, since
their annual mortality can reach between 18 and 33% if cardiac
cause, and between 0 and 12% if the non-cardiac cause (Kapoor,
2002).
There are studies that compared mortality among patients
with syncope of cardiac origin and non-cardiac origin. Among
participants in the Framingham heart Study, 7814 patients were
included from 1971 to 1998 and 822 presented syncope of which
9.5% were cardiac. Adjusted multivariate analysis showed that the
risk of death increased by 31% among all patients with syncope
and was doubled among those with syncope of cardiac origin,
compared with those without syncope. Neurological cause of syn-
cope was also associated with a threefold risk of stroke. Moreover,
there was no association with death or major adverse events
among those with vasovagal syncope (Soteriades et al., 2002).
In the study by Ungar et al. with 380 patients included, death
from any cause occurred in 35 (9.2%) patients during the mean
follow-up of 614 days. Death was considered cardiovascular in
9 patients (26%). And among the patients who died, 82% were
older and had cardiac risk factors such as abnormal ECG and/or
heart disease. In contrast, among those with no abnormal ECG
and/or heart disease, only six (3%) deaths occurred, resulting in a
negative predictive value of 97% (Ungar et al., 2010).
Another study of 200 patients with syncope, cardiac origin
was associated with adverse events defined as death, recurrence of
syncope, cardiovascular events, and major procedures during the
following short-term (1 month) and long (1 year) (Numerosos
et al., 2013).
A study of 37,017 patients with syncope in the period
2001–2009, without previous hospitalization for comorbidities,
and with a control group of 185,085 individuals, demonstrated
increased risk of all-cause mortality, stroke, cardiovascular hospi-
talization, device implantation, and recurrent syncope in healthy
individuals after first admission for syncope (Ruwald et al., 2013).
Another study more recent from the same team, with 70,819
patients hospitalized between 2001 and 2009, aged between 19
and 90 years, with a mean follow up of 3.9 years, showed that
recurrence of syncope, which occurred in 16.4%, was associated
to 3.2 times the risk of death within a year (Ruwald et al., 2014).
Regarding the recurrence of syncope, risk stratification can-
not predict it. The incidence of recurrence of syncope was similar
regardless of cause of syncope. Its rate was 0.3% in the first
month, of 0.8% per month during the first year and 0.5% per
month during the second year. On univariate analysis, predictors
of recurrence were male sex, presence of prodrome and absence of
palpitations (Ungar et al., 2010). On the other hand, the number
of vasovagal syncope events in the preceding year may be a pre-
dictor of recurrence. Those patients with less than two previous
episodes, the recurrence was 22% vs. 69% those with more than 6
episodes, with a probability of 46% (Sumner et al., 2010).
Thus, prognosis is determined by the underlying etiology
specifically the presence and severity of cardiac disease. And it is
imperative to identify its cause and risk stratification for positive
impact in reducing morbidity and mortality.
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